|
| |
|
TUESDAY,
MARCH 27, 2001
|
07:00-08:30
 |
M1
Meet The Expert Session I |
HALL
C |
| |
SEPSIS
AND MENINGOCOCCAL INFECTIONS
M. Levin*, UK |
|
| 07:00-08:30 |
M2
Meet The Expert Session II |
HALL
D |
| |
FUNGAL
INFECTIONS
E. Roilides*, Greece |
|
| 08:45-10:45 |
PL1
PLENARY SESSION I
Chairpersons: M.
Hoogkamp-Korstanje, The Netherlands
G. Kanra, Turkey |
HALL
A |
| 08:45 |
JOHN
SNOW LEARNS FROM LOUIS PASTEUR
S.A. Plotkin*, USA |
|
| 09:15 |
MOLECULAR
EPIDEMIOLOGY AND RATIONAL APPROACH TO VACCINE DEVELOPMENT
R. Moxon*, UK |
|
| 09:45 |
DO
WE NEED NEW VACCINES, OR NEW VACCINE STRATEGIES IN EUROPE?
P.H. Lambert*, Switzerland |
|
| 10:15 |
DETECTING
AND EVALUATING ADVERSE EVENTS FOLLOWING VACCINES: SEPARATING TRUE AND
FALSE ADVERSE REACTIONS
N.A. Halsey*, USA |
|
| 10:45-11:00 |
WM
WALTER MARGET EDUCATIONAL WORKSHOP INAUGURATION |
HALL
A |
| 11:00 |
Coffee
Break and Poster Visit |
|
| 12:15-13:30 |
S5
INFLUENZA IN CHILDREN
Symposium sponsored by: GLAXOSMITHKLINE PHARMA
Chairpersons: A.
Barzilai, Israel
K.J. Henrickson, USA |
HALL
A |
| 12:15 |
INTRODUCTION
A. Barzilai*, Israel |
|
| 12:17 |
THE
BURDEN OF INFLUENZA IN CHILDREN
K.J. Henrickson*, USA |
|
| 12:47 |
TREATMENT
OF PAEDIATRIC INFLUENZA
A. Barzilai*, Israel |
|
| 13:17 |
QUESTIONS
AND ANSWERS |
|
| 13:27 |
SUMMARY
AND CONCLUSIONS
K.J. Henrickson*, USA |
|
| 13:30 |
Lunch
Break |
|
| 14:30-16:30 |
O1
ORAL & SELECTED POSTER PRESENTATIONS I
Chairpersons: S.B.
Black, USA
M. Efrat, Israel |
HALL
A |
| 14:30 |
EFFICACY
OF SEVEN VALENT PNEUMOCOCCAL CONJUGATE VACCINE IN PREMATURE AND LOW
BIRTH WEIGHT INFANTS
H. Shinefield*, S.S. Black, E.M. Lewis, J. Hackell, F. Malinoski, USA |
|
| 14:45 |
INVASIVE
DISEASE EFFICACY OF A 7-VALENT PNEUMOCOCCAL CONJUGATE VACCINE AMONG
NAVAJO AND WHITE MOUNTAIN APACHE (N/WMA)CHILDREN
K.L. O'Brien*, L. Moulton, R. Reid, R. Weatherholtz, J. Hackell, R.
Kohberger, I. Chang, G. Siber, M.
Santosham, USA |
|
| 15:00 |
PARALLEL
EVALUATION OF THE EFFECT OF A 7-VALENT PNEUMOCOCCAL CONJUGATE VACCINE
(PNCCRM)
ON PNEUMOCOCCAL (PNC) CARRIAGE AND ACUTE OTITIS MEDIA (AOM)
T. Kilpi*, R. Syrjanen, A. Palmu, E. Herva, J. Eskola, P.H. Makela,
Finland |
|
| 15:15 |
EFFECTIVENESS
OF PNEUMOCOCCAL CONJUGATE VACCINE FOR THE PREVENTION OF ACUTE OTITIS
MEDIA, BY AGE AND SEASON
B. Fireman*, H. Shinefield, S. Black, E. Lewis, J. Lee, USA |
|
| 15:30 |
FUNCTIONAL
IGA RESPONSES TO PNEUMOCOCCAL POLYSACCHARIDE VACCINE IN HUMAN BREAST
MILK
A. Finn*, Q. Zhang, L. Seymour, C. Fasching, E. Pettitt, E.N. Janoff, UK |
|
| 15:45 |
LENGTH OF NASOPHARYNGEAL CARRIAGE OF PNEUMOCOCCI (PNC) BEFORE
PNEUMOCOCCAL ACUTE OTITIS MEDIA (AOM)
R. Syrjanen*, E. Herva, T. Leino, P.H. Makaela, T. Kilpi, Finland |
|
| SELECTED
POSTERS FOR ORAL PRESENTATION |
| 16:00 |
PNEUMOCOCCAL
CARRIAGE AMONG DAY-CARE CENTER ATTENDEES: A MOLECULAR EPIDEMIOLOGICAL
STUDY
D. Bogaert*, M.N. Engelen, A.J.M. Timmers-Reker, K.C.P. Elzenaar, R. De
Groot, P.W.M. Hermans, The
Netherlands |
|
| 16:07 |
DO
ANTIBODIES TO PNEUMOCOCCAL SURFACE ADHESIN A (PsaA) PREVENT PNEUMOCOCCAL
INVOLVEMENT IN ACUTE OTITIS MEDIA (Pnc AOM)?
S. Rapola*, T. Kilpi, M. Lahdenkari, A.K. Takala, P.H. Makela, H. Kayhty,
Finland |
|
| 16:14 |
IMMUNE
RESPONSES TO NOVEL PNEUMOCOCCAL PROTEIN ANTIGENS (PNEUMOLYSIN, PSPA,
PSAA AND CBPA) IN ADENOIDAL B CELLS FROM CHILDREN
A. Finn*, E. Pettitt, S. Choo, Q. Zhang, UK |
|
| 16:21 |
A
RANDOMIZED, PLACEBO-CONTROLLED STUDY TO EVALUATE THE IMMUNOGENICITY OF
AN 11-VALENT PNEUMOCOCCAL PROTEIN D CONJUGATE VACCINE ADMINISTERED AS
PRIMARY
VACCINATION TO INFANTS AT 6, 10 AND 14 WEEKS OF AGE
S.R. Gatchalian*, C.F. Borja-Tabora, N.R. Bermal, M.H. Hohenboken, P.
Peeters, Philippines |
|
| 16:30 |
Coffee
Break and Exhibition Visit |
|
| 14:30-16:30 |
O2
ORAL & SELECTED POSTER PRESENTATIONS II
Chairpersons: J.A.
Mertsola, Finland
N. Aksaray, Turkey |
HALL
B |
| 14:30 |
TOLL-LIKE
RECEPTORS MEDIATE IMMUNE RESPONSES TO GROUP B STREPTOCOCCI
P. Henneke*, J.A. Van Strijp, H.K. Guttormson, D. Kasper, USA |
|
| 14:45 |
EPIDEMIOLOGICAL
AND CLINICAL ASPECTS OF NEONATAL GROUP B STREPTOCOCCAL INFECTION IN
ISRAEL: A 7-YEAR NATIONWIDE SURVEILLANCE STUDY
M. Efrat*, I. Kassis, A. Barkaei, R. Dagan, Z. Silman, Israel |
|
| 15:00 |
CULTURE
POSITIVE EARLY ONSET GROUP B STREPTOCOCCAL DISEASE - THE TIP OF THE
ICEBERG?
M.J. Torry*, K. D'Agepayeff, S. Luck, A. Pitt, A. Bell, P. Heath, A.
Bedford-Russel, UK |
|
| 15:15 |
PERTUSSIS
AND PARAPERTUSSIS IN DIFFERENT AGE GROUPS IN FINLAND
J.A. Mertsola*, Q. He, K. Rantakokko-Jalava, M. Viljanen, H. Arvilommi,
Finland |
|
| 15:30 |
ITERATIVE
COLONIZATION BY HAEMOPHILUS INFLUENZAE IN HEALTHY CHILDREN LIVING IN AN
ORPHANAGE
J. Raymond*, L. Armand-Lefevre, F. Moulin, H. Dabernat, A. Commeau, P.
Berche, D. Gendrel, France |
|
| 15:45 |
EPIDEMIOLOGY
OF PHARYNGEAL CARRIAGE OF S. PNEUMONIAE, H. INFLUENZAE, AND
M.CATARRHALIS IN HEALTHY TURKISH CHILDREN AT THE ANATOLIAN SIDE OF
ISTANBUL
M. Bakir*, A. Yagci, C. Akbenlioglu, A. Ilki, G. Soyletir, M. Basaran,
Turkey |
|
| SELECTED
POSTERS FOR ORAL PRESENTATION |
| 16:00 |
USE
OF SOLUBLE L-SELECTIN, A MARKER OF IMMUNE ACTIVATION, IN NEONATAL
INFECTION
A.P. Kourtis*, A.T. Kessler, F.K. Lee, USA |
|
| 16:07 |
CLINICAL
SIGNIFICANCE OF HEPATITIS B VIRUS DELETION MUTANTS IN CHRONICALLY
INFECTED CHILDREN
P. Gerner*, H. Schaefer, R. Prange, S. Wirth, Germany |
|
| 16:14 |
DETECTION
OF A NOVEL HEPATOTROPIC DNA VIRUS (SEN-VIRUS) IN CHILDREN
P. Gerner*, C. Foerster, S. Wirth, Germany |
|
| 16:21 |
IS
INTERNET ASSISTANCE WITH ACUTE PAEDIATRIC DIAGNOSIS FEASIBLE?: A PILOT
EVALUATION OF THE 'ISABEL' DIAGNOSTIC TOOL
P. Ramnarayan*, R.C. Tasker, A. Reeve, G. Wilson, S. Nadel, J. Britto,
UK |
|
| 16:30 |
Coffee
Break and Exhibition Visit |
|
| 17:00-18:05 |
BM
YOUNG INVESTIGATOR'S AWARD &
BILL MARSHALL AWARD LECTURE |
HALL
A |
top of page
|
